Automation of Infectious Disease Assays: A Growing Trend in Serology and Molecular Testing
Thank you for your interest in our AACC Workshop "Automation of Infectious Disease Assays: A Growing Trend in Serology and Molecular Testing"
Summary: Infectious disease (ID) testing in the US is rapidly evolving from largely manual assays, often performed as specialized lab functions, to fully automated tests run on routine immunoassay analyzers or molecular platforms. Benefits of automated ID testing for pathogens such as HIV and hepatitis can include decreased turn-around time, improved service levels to physicians and patients, and overall reduction of cost. Automation of other ID immunoassays such as syphilis and EBV should continue to expand menu and allow laboratory consolidation. This workshop focuses on emergent options for the automation of ID testing. In addition, current guidelines and tools for test interpretation for hepatitis, HIV, syphilis, and EBV are reviewed.
- Dr. Patricia R. Slev, Ph.D., DABCC
Assistant Professor of Pathology (Clinical), University of Utah
Medical Director of Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories
Salt Lake City, UT
- Dr. Bruce Hanna, Ph.D.
Professor of Pathology and Microbiology
NYU School of Medicine, Interim Director, Clinical Pathology
Director, Clinical Microbiology and Immunology, Bellevue Hospital
New York, NY
After completion of the following form, you will receive a confirmation email which will include a link to the workshop video.
Because of some maintenance activities, this service is not available currently.
Please try again later.